Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Glaukos (GKOS)
at www.tipranks.com (Thu, 22-Jan 7:30 AM)
at www.tipranks.com (Tue, 20-Jan 8:40 AM)
LifeSci Capital Remains a Buy on Revolution Medicines (RVMD)
at www.tipranks.com (Tue, 20-Jan 8:38 AM)
U.S. Dollar eases as political tensions keep focus on Fed: Currency Recap
at seekingalpha.com (Mon, 19-Jan 2:35 PM)
FDA Breakthrough Therapy Nod for Zoldonrasib Marks Major Milestone for Revolution Medicines
Market Chameleon (Fri, 9-Jan 10:35 AM)
Market Chameleon (Thu, 8-Jan 8:14 AM)
FDA Grants Orphan Drug Status to Daraxonrasib, Targeting Pancreatic Cancer’s Core Mutation
Market Chameleon (Mon, 27-Oct 9:44 AM)